{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T03:33:40Z","timestamp":1791344020512,"version":"4.3.1"},"reference-count":56,"publisher":"American Society of Hematology","issue":"6","content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2005,9,15]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>Natural killer (NK) cell-mediated cytotoxicity is triggered by multiple activating receptors associated with the signaling adaptor protein DNAX activation protein 12\/killer cell-activating receptor-associated protein (DAP12\/KARAP). Here, we show that one of these receptors, NKp44, is present on a subset of natural interferon-producing cells (IPCs) in tonsils. NKp44 expression can also be induced on blood IPCs after in vitro culture with interleukin 3 (IL-3). Crosslinking of NKp44 does not trigger IPC-mediated cytotoxicity but, paradoxically, inhibits interferon \u03b1 (IFN-\u03b1) production by IPCs in response to cytosine-phosphate-guanosine (CpG) oligonucleotides. We find that IPCs in tonsils are in close contact with CD8+ T cells and demonstrate that a subset of memory CD8+ T cells produces IL-3. Therefore, IL-3-mediated induction of NKp44 on IPCs may be an important component of the ongoing crosstalk between the innate and adaptive immune response that allows memory CD8+ T cells to control the IPC response to virus. (Blood. 2005;106: 2076-2082)<\/jats:p>","DOI":"10.1182\/blood-2004-12-4802","type":"journal-article","created":{"date-parts":[[2005,6,8]],"date-time":"2005-06-08T03:14:35Z","timestamp":1118200475000},"page":"2076-2082","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":160,"title":["Paradoxic inhibition of human natural interferon-producing cells by the activating receptor NKp44"],"prefix":"10.1182","volume":"106","author":[{"given":"Anja","family":"Fuchs","sequence":"first","affiliation":[{"name":"From the Department of Pathology and Immunology, Washington University School of Medicine, St Louis, MO; and the Department of Clinical Research, Nagasaki Medical Center of Neurology, Nagasaki, Japan."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marina","family":"Cella","sequence":"additional","affiliation":[{"name":"From the Department of Pathology and Immunology, Washington University School of Medicine, St Louis, MO; and the Department of Clinical Research, Nagasaki Medical Center of Neurology, Nagasaki, Japan."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takayuki","family":"Kondo","sequence":"additional","affiliation":[{"name":"From the Department of Pathology and Immunology, Washington University School of Medicine, St Louis, MO; and the Department of Clinical Research, Nagasaki Medical Center of Neurology, Nagasaki, Japan."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco","family":"Colonna","sequence":"additional","affiliation":[{"name":"From the Department of Pathology and Immunology, Washington University School of Medicine, St Louis, MO; and the Department of Clinical Research, Nagasaki Medical Center of Neurology, Nagasaki, Japan."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"234","reference":[{"key":"2020021220191614600_REF1","doi-asserted-by":"crossref","unstructured":"Colonna M, Trinchieri G, Liu YJ. Plasmacytoid dendritic cells in immunity. Nat Immunol.2004;5: 1219-1226.","DOI":"10.1038\/ni1141"},{"key":"2020021220191614600_REF2","doi-asserted-by":"crossref","unstructured":"Liu YJ. IPC: professional type 1 interferon-producing cells and plasmacytoid dendritic cell precursors. Annu Rev Immunol.2005;23: 275-306.","DOI":"10.1146\/annurev.immunol.23.021704.115633"},{"key":"2020021220191614600_REF3","doi-asserted-by":"crossref","unstructured":"Fitzgerald-Bocarsly P. Natural interferon-alpha producing cells: the plasmacytoid dendritic cells. Biotechniques.2002;(suppl): 16-20, 22, 24-29.","DOI":"10.2144\/Oct0203"},{"key":"2020021220191614600_REF4","doi-asserted-by":"crossref","unstructured":"Iwasaki A, Medzhitov R. Toll-like receptor control of the adaptive immune responses. Nat Immunol.2004;5: 987-995.","DOI":"10.1038\/ni1112"},{"key":"2020021220191614600_REF5","doi-asserted-by":"crossref","unstructured":"Biron CA. Interferons alpha and beta as immune regulators: a new look. Immunity.2001;14: 661-664.","DOI":"10.1016\/S1074-7613(01)00154-6"},{"key":"2020021220191614600_REF6","doi-asserted-by":"crossref","unstructured":"Le Bon A, Tough DF. Links between innate and adaptive immunity via type I interferon. Curr Opin Immunol.2002;14: 432-436.","DOI":"10.1016\/S0952-7915(02)00354-0"},{"key":"2020021220191614600_REF7","unstructured":"Perussia B, Fanning V, Trinchieri G. A leukocyte subset bearing HLA-DR antigens is responsible for in vitro alpha interferon production in response to viruses. Nat Immun Cell Growth Regul.1985;4: 120-137."},{"key":"2020021220191614600_REF8","doi-asserted-by":"crossref","unstructured":"Trinchieri G, Santoli D, Dee RR, Knowles BB. Anti-viral activity induced by culturing lymphocytes with tumor-derived or virus-transformed cells. Identification of the anti-viral activity as interferon and characterization of the human effector lymphocyte subpopulation. J Exp Med.1978;147: 1299-1313.","DOI":"10.1084\/jem.147.5.1299"},{"key":"2020021220191614600_REF9","doi-asserted-by":"crossref","unstructured":"Marrack P, Kappler J, Mitchell T. Type I interferons keep activated T cells alive. J Exp Med.1999;189: 521-530.","DOI":"10.1084\/jem.189.3.521"},{"key":"2020021220191614600_REF10","doi-asserted-by":"crossref","unstructured":"Santini SM, Lapenta C, Logozzi M, et al. Type I interferon as a powerful adjuvant for monocyte-derived dendritic cell development and activity in vitro and in Hu-PBL-SCID mice. J Exp Med.2000;191: 1777-1788.","DOI":"10.1084\/jem.191.10.1777"},{"key":"2020021220191614600_REF11","doi-asserted-by":"crossref","unstructured":"Jego G, Palucka AK, Blanck JP, Chalouni C, Pascual V, Banchereau J. Plasmacytoid dendritic cells induce plasma cell differentiation through type I interferon and interleukin 6. Immunity.2003;19: 225-234.","DOI":"10.1016\/S1074-7613(03)00208-5"},{"key":"2020021220191614600_REF12","doi-asserted-by":"crossref","unstructured":"Poeck H, Wagner M, Battiany J, et al. plasmacytoid dendritic cells, antigen, and CpG-C license human B cells for plasma cell differentiation and immunoglobulin production in the absence of T-cell help. Blood.2004;103: 3058-3064.","DOI":"10.1182\/blood-2003-08-2972"},{"key":"2020021220191614600_REF13","doi-asserted-by":"crossref","unstructured":"Dalod M, Salazar-Mather TP, Malmgaard L, et al. Interferon alpha\/beta and interleukin 12 responses to viral infections: pathways regulating dendritic cell cytokine expression in vivo. J Exp Med.2002;195: 517-528.","DOI":"10.1084\/jem.20011672"},{"key":"2020021220191614600_REF14","doi-asserted-by":"crossref","unstructured":"Penna G, Vulcano M, Roncari A, Facchetti F, Sozzani S, Adorini L. Cutting edge: differential chemokine production by myeloid and plasmacytoid dendritic cells. J Immunol.2002;169: 6673-6676.","DOI":"10.4049\/jimmunol.169.12.6673"},{"key":"2020021220191614600_REF15","doi-asserted-by":"crossref","unstructured":"Krug A, Veeraswamy R, Pekosz A, et al. Interferon-producing cells fail to induce proliferation of naive T cells but can promote expansion and T helper 1 differentiation of antigen-experienced unpolarized T cells. J Exp Med.2003;197: 899-906.","DOI":"10.1084\/jem.20021091"},{"key":"2020021220191614600_REF16","doi-asserted-by":"crossref","unstructured":"Fonteneau JF, Gilliet M, Larsson M, et al. Activation of influenza virus-specific CD4+ and CD8+ T cells: a new role for plasmacytoid dendritic cells in adaptive immunity. Blood.2003;101: 3520-3526.","DOI":"10.1182\/blood-2002-10-3063"},{"key":"2020021220191614600_REF17","doi-asserted-by":"crossref","unstructured":"Schlecht G, Garcia S, Escriou N, Freitas AA, Leclerc C, Dadaglio G. Murine plasmacytoid dendritic cells induce effector\/memory CD8+ T-cell responses in vivo after viral stimulation. Blood.2004;104: 1808-1815.","DOI":"10.1182\/blood-2004-02-0426"},{"key":"2020021220191614600_REF18","doi-asserted-by":"crossref","unstructured":"Blasius A, Vermi W, Krug A, Facchetti F, Cella M, Colonna M. A cell-surface molecule selectively expressed on murine natural interferon-producing cells that blocks secretion of interferon-alpha. Blood.2004;103: 4201-4206.","DOI":"10.1182\/blood-2003-09-3108"},{"key":"2020021220191614600_REF19","doi-asserted-by":"crossref","unstructured":"Yoneyama H, Matsuno K, Zhang Y, et al. Evidence for recruitment of plasmacytoid dendritic cell precursors to inflamed lymph nodes through high endothelial venules. Int Immunol.2004;16: 915-928.","DOI":"10.1093\/intimm\/dxh093"},{"key":"2020021220191614600_REF20","doi-asserted-by":"crossref","unstructured":"Asselin-Paturel C, Brizard G, Pin JJ, Briere F, Trinchieri G. Mouse strain differences in plasmacytoid dendritic cell frequency and function revealed by a novel monoclonal antibody. J Immunol.2003;171: 6466-6477.","DOI":"10.4049\/jimmunol.171.12.6466"},{"key":"2020021220191614600_REF21","doi-asserted-by":"crossref","unstructured":"Ronnblom L, Alm GV. An etiopathogenic role for the type I IFN system in SLE. Trends Immunol.2001;22: 427-431.","DOI":"10.1016\/S1471-4906(01)01955-X"},{"key":"2020021220191614600_REF22","doi-asserted-by":"crossref","unstructured":"Farkas L, Beiske K, Lund-Johansen F, Brandtzaeg P, Jahnsen FL. Plasmacytoid dendritic cells (natural interferon-alpha\/beta-producing cells) accumulate in cutaneous lupus erythematosus lesions. Am J Pathol.2001;159: 237-243.","DOI":"10.1016\/S0002-9440(10)61689-6"},{"key":"2020021220191614600_REF23","doi-asserted-by":"crossref","unstructured":"Zou W, Machelon V, Coulomb-L'Hermin A, et al. Stromal-derived factor-1 in human tumors recruits and alters the function of plasmacytoid precursor dendritic cells. Nat Med.2001;7: 1339-1346.","DOI":"10.1038\/nm1201-1339"},{"key":"2020021220191614600_REF24","doi-asserted-by":"crossref","unstructured":"Vermi W, Bonecchi R, Facchetti F, et al. Recruitment of immature plasmacytoid dendritic cells (plasmacytoid monocytes) and myeloid dendritic cells in primary cutaneous melanomas. Am J Pathol.2003;200: 255-268.","DOI":"10.1002\/path.1344"},{"key":"2020021220191614600_REF25","doi-asserted-by":"crossref","unstructured":"Dzionek A, Sohma Y, Nagafune J, et al. BDCA-2, a novel plasmacytoid dendritic cell-specific type II C-type lectin, mediates antigen capture and is a potent inhibitor of interferon alpha\/beta induction. J Exp Med.2001;194: 1823-1834.","DOI":"10.1084\/jem.194.12.1823"},{"key":"2020021220191614600_REF26","doi-asserted-by":"crossref","unstructured":"Grouard G, Rissoan MC, Filgueira L, Durand I, Banchereau J, Liu YJ. The enigmatic plasmacytoid T cells develop into dendritic cells with interleukin (IL)-3 and CD40-ligand. J Exp Med.1997;185: 1101-1111.","DOI":"10.1084\/jem.185.6.1101"},{"key":"2020021220191614600_REF27","doi-asserted-by":"crossref","unstructured":"Olweus J, BitMansour A, Warnke R, et al. Dendritic cell ontogeny: a human dendritic cell lineage of myeloid origin. Proc Natl Acad Sci U S A.1997;94: 12551-12556.","DOI":"10.1073\/pnas.94.23.12551"},{"key":"2020021220191614600_REF28","doi-asserted-by":"crossref","unstructured":"Facchetti F, Vermi W, Mason D, Colonna M. The plasmacytoid monocyte\/interferon producing cells. Virchows Arch.2003;443: 703-717.","DOI":"10.1007\/s00428-003-0918-8"},{"key":"2020021220191614600_REF29","doi-asserted-by":"crossref","unstructured":"Chaperot L, Bendriss N, Manches O, et al. Identification of a leukemic counterpart of the plasmacytoid dendritic cells. Blood.2001;97: 3210-3217.","DOI":"10.1182\/blood.V97.10.3210"},{"key":"2020021220191614600_REF30","doi-asserted-by":"crossref","unstructured":"Vitale M, Bottino C, Sivori S, et al. NKp44, a novel triggering surface molecule specifically expressed by activated natural killer cells, is involved in non-major histocompatibility complex-restricted tumor cell lysis. J Exp Med.1998;187: 2065-2072.","DOI":"10.1084\/jem.187.12.2065"},{"key":"2020021220191614600_REF31","doi-asserted-by":"crossref","unstructured":"Cantoni C, Bottino C, Vitale M, et al. NKp44, a triggering receptor involved in tumor cell lysis by activated human natural killer cells, is a novel member of the immunoglobulin superfamily. J Exp Med.1999;189: 787-796.","DOI":"10.1084\/jem.189.5.787"},{"key":"2020021220191614600_REF32","doi-asserted-by":"crossref","unstructured":"Campbell KS, Yusa S, Kikuchi-Maki A, Catina TL. NKp44 triggers NK cell activation through DAP12 association that is not influenced by a putative cytoplasmic inhibitory sequence. J Immunol.2004;172: 899-906.","DOI":"10.4049\/jimmunol.172.2.899"},{"key":"2020021220191614600_REF33","doi-asserted-by":"crossref","unstructured":"Sivori S, Parolini S, Marcenaro E, Millo R, Bottino C, Moretta A. Triggering receptors involved in natural killer cell-mediated cytotoxicity against choriocarcinoma cell lines. Hum Immunol.2000;61: 1055-1058.","DOI":"10.1016\/S0198-8859(00)00201-9"},{"key":"2020021220191614600_REF34","doi-asserted-by":"crossref","unstructured":"Sivori S, Parolini S, Marcenaro E, et al. Involvement of natural cytotoxicity receptors in human natural killer cell-mediated lysis of neuroblastoma and glioblastoma cell lines. J Neuroimmunol.2000;107: 220-225.","DOI":"10.1016\/S0165-5728(00)00221-6"},{"key":"2020021220191614600_REF35","doi-asserted-by":"crossref","unstructured":"Arnon TI, Lev M, Katz G, Chernobrov Y, Porgador A, Mandelboim O. Recognition of viral hemagglutinins by NKp44 but not by NKp30. Eur J Immunol.2001;31: 2680-2689.","DOI":"10.1002\/1521-4141(200109)31:9<2680::AID-IMMU2680>3.0.CO;2-A"},{"key":"2020021220191614600_REF36","doi-asserted-by":"crossref","unstructured":"Cooper MA, Fehniger TA, Fuchs A, Colonna M, Caligiuri MA. NK cell and DC interactions. Trends Immunol.2004;25: 47-52.","DOI":"10.1016\/j.it.2003.10.012"},{"key":"2020021220191614600_REF37","doi-asserted-by":"crossref","unstructured":"Ferlazzo G, Thomas D, Lin SL, et al. The abundant NK cells in human secondary lymphoid tissues require activation to express killer cell Ig-like receptors and become cytolytic. J Immunol.2004;172: 1455-1462.","DOI":"10.4049\/jimmunol.172.3.1455"},{"key":"2020021220191614600_REF38","doi-asserted-by":"crossref","unstructured":"Kondo T, Takahashi K, Kohara N, et al. Heterogeneity of presenile dementia with bone cysts (Nasu-Hakola disease): three genetic forms. Neurology.2002;59: 1105-1107.","DOI":"10.1212\/WNL.59.7.1105"},{"key":"2020021220191614600_REF39","doi-asserted-by":"crossref","unstructured":"Cella M, Colonna M. Cloning human natural killer cells. Methods Mol Biol.2000;121: 1-4.","DOI":"10.1385\/1-59259-044-6:1"},{"key":"2020021220191614600_REF40","doi-asserted-by":"crossref","unstructured":"Bouchon A, Dietrich J, Colonna M. Cutting edge: inflammatory responses can be triggered by TREM-1, a novel receptor expressed on neutrophils and monocytes. J Immunol.2000;164: 4991-4995.","DOI":"10.4049\/jimmunol.164.10.4991"},{"key":"2020021220191614600_REF41","doi-asserted-by":"crossref","unstructured":"Nederman T, Karlstrom E, Sjodin L. An in vitro bioassay for quantitation of human interferons by measurements of antiproliferative activity on a continuous human lymphoma cell line. Biologicals.1990;18: 29-34.","DOI":"10.1016\/1045-1056(90)90066-9"},{"key":"2020021220191614600_REF42","doi-asserted-by":"crossref","unstructured":"Vivier E, Nunes JA, Vely F. Natural killer cell signaling pathways. Science.2004;306: 1517-1519.","DOI":"10.1126\/science.1103478"},{"key":"2020021220191614600_REF43","doi-asserted-by":"crossref","unstructured":"McVicar DW, Burshtyn DN. Intracellular signaling by the killer immunoglobulin-like receptors and Ly49. Sci STKE.2001;2001: RE1.","DOI":"10.1126\/stke.2001.75.re1"},{"key":"2020021220191614600_REF44","doi-asserted-by":"crossref","unstructured":"Paloneva J, Kestila M, Wu J, et al. Loss-of-function mutations in TYROBP (DAP12) result in a presenile dementia with bone cysts. Nat Genet.2000;25: 357-361.","DOI":"10.1038\/77153"},{"key":"2020021220191614600_REF45","doi-asserted-by":"crossref","unstructured":"Rissoan MC, Duhen T, Bridon JM, et al. Subtractive hybridization reveals the expression of immunoglobulin-like transcript 7, Eph-B1, granzyme B, and 3 novel transcripts in human plasmacytoid dendritic cells. Blood.2002;100: 3295-3303.","DOI":"10.1182\/blood-2002-02-0638"},{"key":"2020021220191614600_REF46","doi-asserted-by":"crossref","unstructured":"Vermi W, Facchetti F, Rosati S, et al. Nodal and extranodal tumor-forming accumulation of plasmacytoid monocytes\/interferon-producing cells associated with myeloid disorders. Am J Surg Pathol.2004;28: 585-595.","DOI":"10.1097\/00000478-200405000-00004"},{"key":"2020021220191614600_REF47","doi-asserted-by":"crossref","unstructured":"Bave U, Magnusson M, Eloranta ML, Perers A, Alm GV, Ronnblom L. Fc gamma RIIa is expressed on natural IFN-alpha-producing cells (plasmacytoid dendritic cells) and is required for the IFN-alpha production induced by apoptotic cells combined with lupus IgG. J Immunol.2003;171: 3296-3302.","DOI":"10.4049\/jimmunol.171.6.3296"},{"key":"2020021220191614600_REF48","doi-asserted-by":"crossref","unstructured":"Means TK, Latz E, Hayashi F, Murali MR, Golenbock DT, Luster AD. Human lupus autoantibody-DNA complexes activate DCs through cooperation of CD32 and TLR9. J Clin Invest.2005;115: 407-417.","DOI":"10.1172\/JCI23025"},{"key":"2020021220191614600_REF49","doi-asserted-by":"crossref","unstructured":"Green DS, Lum T, Green JA. IgG-derived Fc down-regulates virus-induced plasmacytoid dendritic cell (pDC) IFNalpha production. Cytokine.2004;26: 209-216.","DOI":"10.1016\/j.cyto.2004.02.012"},{"key":"2020021220191614600_REF50","doi-asserted-by":"crossref","unstructured":"Sutterwala FS, Noel GJ, Salgame P, Mosser DM. Reversal of proinflammatory responses by ligating the macrophage Fcgamma receptor type I. J Exp Med.1998;188: 217-222.","DOI":"10.1084\/jem.188.1.217"},{"key":"2020021220191614600_REF51","doi-asserted-by":"crossref","unstructured":"Mosser DM. The many faces of macrophage activation. J Leukoc Biol.2003;73: 209-212.","DOI":"10.1189\/jlb.0602325"},{"key":"2020021220191614600_REF52","doi-asserted-by":"crossref","unstructured":"Nakajima H, Cella M, Bouchon A, et al. Patients with X-linked lymphoproliferative disease have a defect in 2B4 receptor-mediated NK cell cytotoxicity. Eur J Immunol.2000;30: 3309-3318.","DOI":"10.1002\/1521-4141(200011)30:11<3309::AID-IMMU3309>3.0.CO;2-3"},{"key":"2020021220191614600_REF53","doi-asserted-by":"crossref","unstructured":"Sallusto F, Geginat J, Lanzavecchia A. Central memory and effector memory T cell subsets: function, generation, and maintenance. Annu Rev Immunol.2004;22: 745-763.","DOI":"10.1146\/annurev.immunol.22.012703.104702"},{"key":"2020021220191614600_REF54","doi-asserted-by":"crossref","unstructured":"Bleharski JR, Li H, Meinken C, et al. Use of genetic profiling in leprosy to discriminate clinical forms of the disease. Science.2003;301: 1527-1530.","DOI":"10.1126\/science.1087785"},{"key":"2020021220191614600_REF55","doi-asserted-by":"crossref","unstructured":"Ravetch JV, Lanier LL. Immune inhibitory receptors. Science.2000;290: 84-89.","DOI":"10.1126\/science.290.5489.84"},{"key":"2020021220191614600_REF56","unstructured":"Pasquier B, Launay P, Kanamaru Y, et al. Identification of FcalphaRI as an inhibitory receptor that controls inflammation: dual role of FcRgamma ITAM. Immunity.2005;22: 31-42."}],"container-title":["Blood"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/ashpublications.org\/blood\/article-pdf\/106\/6\/2076\/1634700\/zh801805002076.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/ashpublications.org\/blood\/article-pdf\/106\/6\/2076\/1634700\/zh801805002076.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,2,13]],"date-time":"2020-02-13T01:39:01Z","timestamp":1581557941000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/blood\/article\/106\/6\/2076\/21595\/Paradoxic-inhibition-of-human-natural"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,9,15]]},"references-count":56,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2005,9,15]]}},"URL":"https:\/\/doi.org\/10.1182\/blood-2004-12-4802","relation":{},"ISSN":["0006-4971","1528-0020"],"issn-type":[{"value":"0006-4971","type":"print"},{"value":"1528-0020","type":"electronic"}],"subject":[],"published":{"date-parts":[[2005,9,15]]}}}